Latest / The Carrie Abbott Show
Worst Scenario Coming True
The pre-print of a new study published in the Journal of Infection finds that antibody dependent enhancement (ADE) is a concern for COVID-19 vaccine recipients exposed to the SARS-COV-2 Delta variant. Bernadette Pajer with Informed Choice WA explains the results and addresses other COVID concerns.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.